Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Unmarked vials or generic-looking pens are red flags
For example, if semaglutide is placed on the specialty tier, Part D plans could charge 25% to 33% of the retail drug cost." Even with a restrictive definition of CVD and low persistent use rates around 30%, as seen among commercially insured users without diabetes, semaglutide could still add more than $10 billion in annual federal spending, making it one of the costliest drugs under Medicare Part Dhighlighting the urgent need for policy solutions to manage the budgetary impact as access to semaglutide expands
Our tiered pricing is transparent and straightforward, with no restrictions or eligibility conditions
risk difference: 0.7% (95% confidence interval (CI): 1.2% to 0.2%)
